RCAMU
IDXX icon

Rothschild & Co Asset Management US’s Idexx Laboratories IDXX Stock Holding History

Rothschild & Co Asset Management US’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,492
Closed -$402K – 450
2017
Q2 		$402K Sell
2,492
-368
-13% -$59.8K ﹤0.01% 560
2017
Q1 		$442K Sell
2,860
-976
-25% -$135K 0.01% 539
2016
Q4 		$450K Sell
3,836
-308
-7% -$35.1K 0.01% 535
2016
Q3 		$467K Sell
4,144
-405
-9% -$42.7K 0.01% 480
2016
Q2 		$422K Buy
4,549
+539
+13% +$46.3K 0.01% 460
2016
Q1 		$314K Buy
4,010
+532
+15% +$38.3K 0.01% 463
2015
Q4 		$254K Buy
+3,478
New +$248K ﹤0.01% 431

Other funds holding IDXX

Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Rothschild & Co Asset Management US's IDXX Position: Q3 2017 in Review

Rothschild & Co Asset Management US sold out of Idexx Laboratories (IDXX) in Q3 2017, closing a stake of 2,492 shares — an estimated $402K sold.

Rothschild & Co Asset Management US first reported a position in IDXX in Q4 2015 and held it in 7 quarters. The position peaked at $467K in Q3 2016. 573 funds tracked by Wall St. Rank hold IDXX as of Q3 2017.

  • Rothschild & Co Asset Management US reported no remaining Idexx Laboratories position as of Q3 2017 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 2,492 Idexx Laboratories shares in Q3 2017, an estimated $402K.
  • Rothschild & Co Asset Management US first reported a position in Idexx Laboratories in Q4 2015 and held it in 7 quarters.
  • Rothschild & Co Asset Management US's Idexx Laboratories position peaked at $467K in Q3 2016.
  • 573 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2017.

Based on Rothschild & Co Asset Management US's 13F filing for Q3 2017, filed 8 Nov 2017.